Application 016954

Type
NDA
Sponsor
JANSSEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MICRONORNORETHINDRONETABLET;ORAL-280.35MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50458-194Ortho MicronorNORETHINDRONEJanssen Pharmaceuticals, Inc.NDACurrent
50458-194Ortho MicronorNORETHINDRONEJanssen Pharmaceuticals, Inc.NDACurrent
50458-194Ortho MicronorNORETHINDRONEJanssen Pharmaceuticals, Inc.NDACurrent
50458-194Ortho MicronorNORETHINDRONEJanssen Pharmaceuticals, Inc.NDACurrent
50458-194Ortho MicronorNORETHINDRONEJanssen Pharmaceuticals, Inc.NDACurrent
52544-892JolivetteNORETHINDRONEActavis Pharma, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
69332SUPPL2021-11-17
69331SUPPL2021-11-17
69324SUPPL2021-11-16
69323SUPPL2021-11-16
33210SUPPL2014-07-02
13061SUPPL2014-06-19
10940SUPPL2008-06-26
13060SUPPL2008-06-24
13059SUPPL2003-10-09